There was a study to check GAP-43 levels in the early stage [71] and late stage of Alzheimer’s disease and Parkinson’s disease [72, 73] when GAP-43 was mainly reduced. Here, GAP43 is linked to early-onset autosomal dominant Alzheimer disease.